378 related articles for article (PubMed ID: 32759338)
1. Molecular Elucidation of Riboflavin Production and Regulation in Candida albicans, toward a Novel Antifungal Drug Target.
Demuyser L; Palmans I; Vandecruys P; Van Dijck P
mSphere; 2020 Aug; 5(4):. PubMed ID: 32759338
[No Abstract] [Full Text] [Related]
2. Dihydrofolate Reductase Is a Valid Target for Antifungal Development in the Human Pathogen
DeJarnette C; Luna-Tapia A; Estredge LR; Palmer GE
mSphere; 2020 Jun; 5(3):. PubMed ID: 32581079
[TBL] [Abstract][Full Text] [Related]
3. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
[No Abstract] [Full Text] [Related]
4. Riboflavin Targets the Cellular Metabolic and Ribosomal Pathways of Candida albicans
Lei J; Huang J; Xin C; Liu F; Zhang J; Xie Y; Mao Y; Chen W; Song Z
Microbiol Spectr; 2023 Feb; 11(1):e0380122. PubMed ID: 36625571
[TBL] [Abstract][Full Text] [Related]
5.
Gong Y; Li T; Yu C; Sun S
Front Cell Infect Microbiol; 2017; 7():520. PubMed ID: 29312897
[TBL] [Abstract][Full Text] [Related]
6. Pathway analysis of Candida albicans survival and virulence determinants in a murine infection model.
Becker JM; Kauffman SJ; Hauser M; Huang L; Lin M; Sillaots S; Jiang B; Xu D; Roemer T
Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22044-9. PubMed ID: 21135205
[TBL] [Abstract][Full Text] [Related]
7. Loss of Upc2p-Inducible
Luna-Tapia A; Willems HME; Parker JE; Tournu H; Barker KS; Nishimoto AT; Rogers PD; Kelly SL; Peters BM; Palmer GE
mBio; 2018 May; 9(3):. PubMed ID: 29789366
[TBL] [Abstract][Full Text] [Related]
8. Riboflavin and pantothenic acid biosynthesis are crucial for iron homeostasis and virulence in the pathogenic mold Aspergillus fumigatus.
Dietl AM; Meir Z; Shadkchan Y; Osherov N; Haas H
Virulence; 2018; 9(1):1036-1049. PubMed ID: 30052132
[TBL] [Abstract][Full Text] [Related]
9. Histone acetylation/deacetylation in
Su S; Li X; Yang X; Li Y; Chen X; Sun S; Jia S
Future Microbiol; 2020 Jul; 15():1075-1090. PubMed ID: 32854542
[TBL] [Abstract][Full Text] [Related]
10. Human fungal pathogen Candida albicans in the postgenomic era: an overview.
Kabir MA; Hussain MA
Expert Rev Anti Infect Ther; 2009 Feb; 7(1):121-34. PubMed ID: 19622061
[TBL] [Abstract][Full Text] [Related]
11. A chemical screen identifies structurally diverse metal chelators with activity against the fungal pathogen
Fallah S; Duncan D; Reichl KD; Smith MJ; Wang W; Porco JA; Brown LE; Whitesell L; Robbins N; Cowen LE
Microbiol Spectr; 2024 Apr; 12(4):e0409523. PubMed ID: 38376363
[No Abstract] [Full Text] [Related]
12. Harnessing Metal Homeostasis Offers Novel and Promising Targets Against Candida albicans.
Hameed S; Hans S; Singh S; Fatima Z
Curr Drug Discov Technol; 2020; 17(4):415-429. PubMed ID: 30827249
[TBL] [Abstract][Full Text] [Related]
13. Potential Targets for Antifungal Drug Discovery Based on Growth and Virulence in Candida albicans.
Li X; Hou Y; Yue L; Liu S; Du J; Sun S
Antimicrob Agents Chemother; 2015 Oct; 59(10):5885-91. PubMed ID: 26195510
[TBL] [Abstract][Full Text] [Related]
14.
Ke CL; Liao YT; Lin CH
Virulence; 2021 Dec; 12(1):281-297. PubMed ID: 33427576
[No Abstract] [Full Text] [Related]
15. In vivo imaging of disseminated murine Candida albicans infection reveals unexpected host sites of fungal persistence during antifungal therapy.
Jacobsen ID; Lüttich A; Kurzai O; Hube B; Brock M
J Antimicrob Chemother; 2014 Oct; 69(10):2785-96. PubMed ID: 24951534
[TBL] [Abstract][Full Text] [Related]
16. Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29.
Shekhar-Guturja T; Tebung WA; Mount H; Liu N; Köhler JR; Whiteway M; Cowen LE
Antimicrob Agents Chemother; 2016 Dec; 60(12):7468-7480. PubMed ID: 27736764
[TBL] [Abstract][Full Text] [Related]
17. Calcium-calcineurin signaling pathway in Candida albicans: A potential drug target.
Li W; Shrivastava M; Lu H; Jiang Y
Microbiol Res; 2021 Aug; 249():126786. PubMed ID: 33989979
[TBL] [Abstract][Full Text] [Related]
18.
Ponde NO; Lortal L; Ramage G; Naglik JR; Richardson JP
Crit Rev Microbiol; 2021 Feb; 47(1):91-111. PubMed ID: 33482069
[No Abstract] [Full Text] [Related]
19. Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery.
Roemer T; Jiang B; Davison J; Ketela T; Veillette K; Breton A; Tandia F; Linteau A; Sillaots S; Marta C; Martel N; Veronneau S; Lemieux S; Kauffman S; Becker J; Storms R; Boone C; Bussey H
Mol Microbiol; 2003 Oct; 50(1):167-81. PubMed ID: 14507372
[TBL] [Abstract][Full Text] [Related]
20. Selective BET bromodomain inhibition as an antifungal therapeutic strategy.
Mietton F; Ferri E; Champleboux M; Zala N; Maubon D; Zhou Y; Harbut M; Spittler D; Garnaud C; Courçon M; Chauvel M; d'Enfert C; Kashemirov BA; Hull M; Cornet M; McKenna CE; Govin J; Petosa C
Nat Commun; 2017 May; 8():15482. PubMed ID: 28516956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
